AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,062.00p
   
  • Change Today:
      93.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,501.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.30m
  • Volume: 2,714,221
  • Market Cap: £155,992m
  • RiskGrade: 123
  • Beta: 0.87

Newspaper Links

AstraZeneca boss says staff in China breached ru... 13-Nov-2024 Times
AstraZeneca raises forecasts amid investigations... 12-Nov-2024 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian
AstraZeneca pours cash into research and develop... 07-Nov-2014 Daily Mail
AstraZeneca raises sales outlook as rival drugs ... 07-Nov-2014 The Independent
AstraZeneca shares fall as Obama thwarts tax inv... 24-Sep-2014 Guardian
As battle over AstraZeneca looms, one lab in Slo... 01-Sep-2014 Guardian
Round two: Window opens for Pfizer move on Astra... 26-Aug-2014 Daily Mail
Share hunter: Upbeat Pfizer looks like a healthy... 26-Aug-2014 Express & Star
THURSDAY MARKET CLOSE: AstraZeneca buyout back i... 22-Aug-2014 The Scotsman
MARKET REPORT: Pfizer in wings boosts Astra- Zen... 22-Aug-2014 Express & Star
Astrazeneca predict healthy sales 01-Aug-2014 Express & Star
AstraZeneca boosts its lung drugs power with $2b... 31-Jul-2014 Guardian
Astrazeneca restocks with Almirall asthma-drug d... 31-Jul-2014 Express & Star
Round two: Pfizer set to launch a second attempt... 30-Jul-2014 Daily Mail
Pfizer defends £69bn move for AstraZeneca 30-Jul-2014 Telegraph

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,062.00p
Change Today 93.00p
% Change 0.93 %
52 Week High 13,276.00p
52 Week Low 9,501.00p
Volume 2,714,221
Shares Issued 1,550.30m
Market Cap £155,992m
Beta 0.87
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income
78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 21-Nov-2024

Time Volume / Share Price
16:03 0 @ 10,030.00p
15:34 0 @ 9,999.00p
15:18 1 @ 10,014.00p
15:20 0 @ 9,999.00p
15:18 0 @ 10,016.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page